Founded in 2025, Kardiaport is building the world's most advanced tool for predicting heart disease. We set up Kardiaport because we believe wearable technology can radically improve detection of heart disease.

​

Cardiovascular disease continues to be the leading cause of death globally, and therefore tackling the challenges it poses to society is Kardiaport’s priority. We aim to truly make a difference by enabling earlier detection and prevention of cardiovascular disease.

​

Current methods of diagnosing heart disease and assessing stroke risk often rely on episodic static monitoring, which can miss intermittent arrhythmias and early signs of cerebrovascular events. Wearable devices equipped with real-time monitoring sensors provide an opportunity for continuous cardiac data collection and stroke risk assessment.

​​​

​

​​